Rhythm Pharmaceuticals Inc (RYTM): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 140,529 US Dollar | 12 | 5 | 2 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 68.852.082 | 16,11 | 13,64 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Rhythm Pharmaceuticals Inc
Mitarbeiter 414
Handelsplatz NASDAQ
Ticker Symbol RYTM
IPO Datum 2017-10-05
Adresse 222 Berkeley Street, Boston, MA, United States, 02116
Webseite https://rhythmtx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. David P. Meeker M.D. | Chairman, President & CEO |
| 2 | Mr. Hunter C. Smith M.B.A. | CFO & Treasurer |
| 3 | Dr. Alastair Garfield Ph.D. | Chief Scientific Officer |
| 4 | Mr. Yann Mazabraud | Executive VP & Head of International |
| 5 | Ms. Jennifer Lee | Executive VP & Head of North America |
| 6 | Mr. Christopher P. German | Corporate Controller & Principal Accounting Officer |
| 7 | Mr. Joseph Shulman | Chief Technical Officer |
| 8 | Mr. David Connolly | Head of Investor Relations & Corporate Communications |
| 9 | Mr. Jim Flaherty | Senior VP & General Counsel |
| 10 | Ms. Sarah Ryan | Vice President of Sales & Marketing |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | RA Capital Management, LLC | 9,68% | 0,62 Mrd. USD |
| 2 | BlackRock Inc | 8,94% | 0,58 Mrd. USD |
| 3 | Baker Bros Advisors LP | 8,14% | 0,53 Mrd. USD |
| 4 | PRIMECAP Management Company | 4,60% | 0,30 Mrd. USD |
| 5 | Vanguard Portfolio Management, LLC | 4,56% | 0,29 Mrd. USD |
| 6 | Vanguard Capital Management, LLC | 4,37% | 0,28 Mrd. USD |
| 7 | JPMorgan Chase & Co | 3,85% | 0,25 Mrd. USD |
| 8 | Perceptive Advisors LLC | 3,76% | 0,24 Mrd. USD |
| 9 | State Street Corp | 3,74% | 0,24 Mrd. USD |
| 10 | T. Rowe Price Associates, Inc. | 3,73% | 0,24 Mrd. USD |
| 11 | Westfield Capital Management Company, L.P. | 3,21% | 0,21 Mrd. USD |
| 12 | The Goldman Sachs Group Inc | 3,09% | 0,20 Mrd. USD |
| 13 | Federated Hermes Inc | 2,59% | 0,17 Mrd. USD |
| 14 | Polar Capital Holdings PLC | 2,42% | 0,16 Mrd. USD |
| 15 | Geode Capital Management, LLC | 2,23% | 0,14 Mrd. USD |
| 16 | Capital Research Global Investors | 2,23% | 0,14 Mrd. USD |
| 17 | Citadel Advisors Llc | 1,84% | 0,12 Mrd. USD |
| 18 | Checkpoint Capital LP | 1,72% | 0,11 Mrd. USD |
| 19 | Siren, L.L.C. | 1,65% | 0,11 Mrd. USD |
| 20 | Morgan Stanley - Brokerage Accounts | 1,62% | 0,10 Mrd. USD |